mBio

Gastroenterology

Fighting E. coli with E. coli

According to findings published this week in mBio, Nissle, a strain of Escherichia coli, is harmless to intestinal tissue and may protect the gut from enterohemorrhagic E. coli, a pathogen that produces Shiga toxin.

Diseases, Conditions, Syndromes

MMR vaccine could protect against the worst symptoms of COVID-19

Administering the MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection, say a team of experts in this week's mBio, a journal of the American ...

Vaccination

How to improve the pneumococcus vaccine

Vaccines that protect people from infection by Streptococcus pneumoniae, which kills up to 1 million children ever year worldwide, train the immune system to recognize the pathogen's thick sugar capsule. Pneumococcus capsules ...

Immunology

Study shows CRISPR effectiveness against colitis pathogen

Research at North Carolina State University shows that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen that causes colitis—a ...

Medical research

Obesity promotes virulence of influenza

Obesity promotes the virulence of the influenza virus, according to a study conducted in mice published in mBio, an open-access journal of the American Society for Microbiology. The finding could explain, in part, why the ...

Diseases, Conditions, Syndromes

Double success for drug resistance research

Swansea University research into the threat posed by antifungal drug resistance has been highlighted in two prestigious international journals.

page 9 from 27